Herald KeeperSynthetic Biology Tools Market Report 2018: Analysis of Global Demand and Supply Forecast to 2025Expert ConsultingSynthetic Biology Tools Market offers expounded data on the business. This report studies the global Synthetic Biology Tools … Continue reading
Investorplace.comAfter Soaring to New Highs, Crispr Therapeutics AG Stock Ripe for a FallInvestorplace.comQuite often in stock markets, companies that offer something novel and unique attract speculators. So, when Crispr Therapeutics AG (NASDAQ:CRSP) q… Continue reading
Life Sciences Intellectual Property ReviewZFN: a rival to CRISPRLife Sciences Intellectual Property ReviewWhile CRISPR gene-editing and the battle over its patents continue to dominate headlines, a lesser known contender is making a name for itself, pa… Continue reading
TAPinto.netImmunotherapy Clinical Trial at Overlook Medical Center Reveals Brain Tumor Shrinkage, Continues with Phase 3 StudyTAPinto.netSUMMIT, NJ – Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with… Continue reading
NPR |
Experimental immune treatment saves dying breast cancer patient
NBCNews.com It wasn’t looking good for Judy Perkins. Her breast cancer had come back with a vengeance after a 2003 mastectomy and she had big tumors in her chest and on her liver. But an experimental new approach that combines new immunotherapy drugs with a … Therapy Made From Patient’s Immune System Shows Promise For Advanced Breast CancerNPR New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast CancerForbes Immune-System Therapy Eradicated Breast Cancer in New BreakthroughBloomberg Los Angeles Times –The Independent –Lewiston Morning Tribune all 512 news articles » |